Trinseo (NYSE: TSE), the global materials company and manufacturer of plastics, latex binders and synthetic rubber, will exhibit at Medical Manufacturing Asia 2016 from August 31 – September 2, at Marina Bay Sands, Singapore at Booth 2L–16.
Trinseo has served the global medical devices market for nearly three decades. Part of the Dow Chemical Company until 2010, the company offers worldwide production and fulfillment, and recently introduced its medical compounding capability in Asia Pacific to complement its existing compounding in Europe and North America. These facilities are sourced with polycarbonate base resins from Trinseo’s highest quality, medically-equivalent resins produced in Germany and from its joint venture partner in Japan.
These materials address some of the industry’s critical challenges, including the miniaturization of medical instruments, the increase in home health care and point-of-care treatment, and the need to produce lighter weight devices.
Interested in arranging a meeting with Trinseo at Medical Manufacturing Asia 2016 in Singapore? Contact Gregory Seah at email@example.com.
Trinseo (NYSE: TSE), a specialty material solutions provider, partners with companies to bring ideas to life in an imaginative, smart, and sustainability-focused manner by combining its premier expertise, forward-looking innovations and best-in-class materials to unlock value for companies and consumers.
From design to manufacturing, Trinseo taps into decades of experience in diverse material solutions to address customers’ unique challenges in a wide range of industries, including consumer goods, mobility, building and construction, and medical.
Trinseo’s approximately 3,400 employees bring endless creativity to reimagining the possibilities with clients all over the world from the company’s locations in North America, Europe, and Asia Pacific. Trinseo reported net sales of approximately $4.8 billion in 2021. Discover more by visiting www.trinseo.com and connecting with Trinseo on LinkedIn, Twitter, Facebook and WeChat.